Whether you're a physician considering this for your patients, a concierge practice exploring a standing referral relationship, or a research or pharmaceutical partner, we're glad to talk through the details that matter to you.
Refer patients ahead of treatments that may compromise immune cell health—chemotherapy, radiation, or other immune-affecting therapies—so a healthy sample is banked in advance.
Introduce immune cell banking to your patient population through a trusted physician relationship, as a standing part of preventive or longevity-focused care.
Explore research collaboration, access to de-identified data, or clinical study partnerships around immune cell banking and cell-based therapies.
We start by understanding your patient population, practice structure, or research goals—no commitment, just a conversation about whether this makes sense for you.
For practice and network partnerships, we typically begin with a pilot group before expanding—so you can evaluate participation, operations, and fit before scaling.
Physicians receive a straightforward referral process for patients; research partners receive access to de-identified data and collaboration terms defined in a separate agreement.
We keep partners informed as our clinical and research work evolves, and welcome ongoing dialogue about what would make the relationship more useful to you.
We isolate and cryopreserve peripheral blood mononuclear cells (PBMCs)—including T cell subsets (CD4/CD8, naive/central memory/effector), B cells, monocytes, and NK cells—via flow cytometry, working with CLIA- and CAP-accredited lab partners.
Available to physicians and institutional partners on request:
As with all Immunaeon services: analyses are informational, not diagnostic, and are not a substitute for clinical judgment.
Leave your email and we'll send our processing methodology, referral workflow, and partnership terms directly.
No obligation, no pressure—just a conversation about your patients, your practice, or your research.
Start a conversation